Article Details
Retrieved on: 2019-04-18 07:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>IBM Watson</b> Health is tapering off its Drug Discovery program, which uses "AI" software to help companies develop new pharmaceuticals, blaming ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here